Esperion Therapeutics Inc. (ESPR)
NASDAQ · Healthcare
Esperion Therapeutics Inc. Cash on Hand 2018–2025
Esperion Therapeutics Inc. annual/quarterly cash on hand history from 2018 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Esperion Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 167.9M, a 15.95% increase year-over-year.
- Esperion Therapeutics Inc. cash on hand for 2025 were 167.9M, a 15.95% increase from 2024.
- Esperion Therapeutics Inc. cash on hand for 2024 were 144.8M, a 76.01% increase from 2023.
- Esperion Therapeutics Inc. cash on hand for 2023 were 82.2M, a 34.08% decrease from 2022.
- Esperion Therapeutics Inc. cash on hand for 2022 were 124.8M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Esperion Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $168 |
| 2024 | $145 |
| 2023 | $82 |
| 2022 | $125 |
| 2021 | $209 |
| 2020 | $305 |
| 2019 | $166 |
| 2018 | $37 |
| Esperion Therapeutics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $168 |
| 2024-12-31 | $145 |
| 2023-12-31 | $82 |
| 2022-12-31 | $125 |
| 2021-12-31 | $209 |
| 2020-12-31 | $305 |
| 2019-12-31 | $166 |
| 2018-12-31 | $37 |
Esperion Therapeutics Inc. Cash on Hand — FAQ
Esperion Therapeutics Inc. (ESPR) cash on hand over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ESPR's cash on hand history?
The chart and table above show Esperion Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.